Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women

Obstetrics and Gynecology

Volumn 111, Issue 5, 2008, Pages 1103-1110

  Kahn, Jessica A ^a   Rosenthal, Susan L ^b   Jin, Yan ^b   Huang, Bin ^b   Namakydoust, Azadeh ^b   Zimet, Gregory D ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SELF CONCEPT; SEXUALLY TRANSMITTED DISEASE; VACCINATION; VIRUS INFECTION; WART VIRUS;

ADOLESCENT; ADULT; ATTITUDE TO HEALTH; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; LOGISTIC MODELS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PREVALENCE; VACCINATION;

EID: 42949171490     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31817051fa     Document Type: Article

References (25)

1. Centers for Disease Control and Prevention. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2007;56:1-24.
2. Holden G. The relationship of self-efficacy appraisals to subsequent health related outcomes: a meta-analysis. Soc Work Health Care 1991;16:53-93.
3. Armitage CJ, Conner M. Efficacy of the theory of planned behaviour: a meta-analytic review. Br J Soc Psychol 2001;40:471-99.
4. Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process 1991;50:179-211.
5. Strecher VJ, DeVellis BM, Becker MH, Rosenstock IM. The role of self-efficacy in achieving health behavior change. Health Educ Q 1986;13:73-92.
6. Kahn JA, Lan D, Kahn RS. Sociodemographic factors associated with high-risk human papillomavirus infection. Obstet Gynecol 2007;110:87-95.
7. Wetzel C, Tissot A, Kollar LM, Hillard PA, Stone R, Kahn JA. Development of an HPV Educational Protocol for Adolescents. J Pediatr Adolesc Gynecol 2007;20:281-7.
8. Kahn JA, Rosenthal SL, Hamann T, Bernstein DI. Attitudes about human papillomavirus vaccine in young women. Int J STD AIDS 2003;14:300-6.
9. Kahn JA, Slap GB, Bernstein DI, Kollar LM, Tissot AM, Hillard PA, et al. Psychological, behavioral, and interpersonal impact of human papillomavirus and Pap test results. J Womens Health (Larchmt) 2005;14:650-9.
10. Kahn JA, Slap GB, Bernstein DI, Tissot AM, Kollar LM, Hillard PA, et al. Personal meaning of human papillomavirus and Pap test results in adolescent and young adult women. Health Psychol 2007;26:192-200.
11. Schneider G, Rosenthal SL, Lan D, Huang B, Kahn JA. HPV-related stigma in female adolescents. J Adolesc Health 2006;38:107.
12. Kahn JA, Slap GB, Huang B, Rosenthal SL, Wanchick AM, Kollar LM, et al. Comparison of adolescent and young adult self-collected and clinician-collected samples for human papillomavirus. Obstet Gynecol 2004;103:952-9.
13. Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, Hildesheim A, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000;38:357-61.
14. McDonald RP. Factor analysis and related methods. Hillsdale, NJ: Lawrence Erlbaum Associates; 1985.
15. Tarkowski TA, Koumans EH, Sawyer M, Pierce A, Black CM, Papp JR, et al. Epidemiology of human papillomavirus infection and abnormal cytologic test results in an urban adolescent population. J Infect Dis 2004;189:46-50.
16. Brown DR, Shew ML, Qadadri B, Neptune N, Vargas M, Tu W, et al. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis 2005;191:182-92.
17. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, et al. Prevalence of HPV infection among females in the United States. JAMA 2007;297:813-9.
18. Skinner SR, Nolan T, Bowes G. Measles-mumps-rubella and hepatitis B vaccination uptake in adolescents: a survey in metropolitan Melbourne. Med J Aust 1998;168:546-9.
19. Gerend MA, Lee SC, Shepherd JE. Predictors of human papillomavirus vaccination acceptability among underserved women. Sex Transm Dis 2007;34:468-71.
20. Sauvageau C, Duval B, Gilca V, Lavoie F, Ouakki M. Human papilloma virus vaccine and cervical cancer screening acceptability among adults in Quebec, Canada. BMC Public Health 2007;7:304.
21. Scarinci IC, Garcés-Palacio IC, Partridge EE. An examination of acceptability of HPV vaccination among African American women and Latina immigrants. J Womens Health (Larchmt) 2007;16:1224-33.
22. Constantine NA, Jerman P. Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolesc Health 2007;40:108-15.
23. Kahn JA. Maximizing the potential public health impact of HPV vaccines: a focus on parents. J Adolesc Health 2007;40:101-3.
24. Kahn JA, Rosenthal SL, Tissot AM, Bernstein DI, Wetzel C, Zimet GD. Factors influencing pediatricians' intention to recommend human papillomavirus vaccines. Ambul Pediatr 2007;7:367-73.
25. Tissot AM, Zimet GD, Rosenthal SL, Bernstein DI, Wetzel C, Kahn JA. Effective strategies for HPV vaccine delivery: the views of pediatricians. J Adolesc Health 2007;41:119-25.